Niha Zubair1, Charles Kooperberg2, Jingmin Liu3, Chongzhi Di2, Ulrike Peters4, Marian L Neuhouser4. 1. Cancer Prevention Program, nzubair@fhcrc.org. 2. Biostatistics and Biomathematics Program, and. 3. Women's Health Initiative Clinical Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA. 4. Cancer Prevention Program.
Abstract
BACKGROUND: The consumption and blood concentrations of lycopene are both positively and inversely associated with the risk of several chronic diseases. The inconsistences in lycopene disease association studies may stem from a lack of knowledge about the genetic variation in the synthesis, metabolism, and deposition of transport and binding proteins, which potentially influence serum lycopene concentrations. OBJECTIVE: We examined the association between variation across the genome and serum concentrations of lycopene in a multiethnic population. METHODS: Participants included African (n = 914), Hispanic (n = 464), and European (n = 1203) American postmenopausal women from the Women's Health Initiative. We analyzed ∼7 million single nucleotide polymorphisms (SNPs). Linear regression models were used to assess associations between each SNP and serum concentrations (log transformed, continuous) of lycopene; we adjusted for age, body mass index, and population substructure. Models were run separately by ethnicity, and results were combined in a transethnic fixed-effects meta-analysis. RESULTS: In the meta-analysis, the scavenger receptor class B, member 1 (SCARB1) gene, which encodes for a cholesterol membrane transporter, was significantly associated with lycopene concentrations (rs1672879; P < 2.68 × 10(-9)). Each additional G allele resulted in a 12% decrease in lycopene concentrations for African Americans, 20% decrease for Hispanic Americans, and 9% decrease for European Americans. In addition, 2 regions were significantly associated with serum lycopene concentrations in African Americans: the slit homolog 3 gene (SLIT3), which serves as a molecular guidance cue in cellular migration, and the dehydrogenase/reductase (SDR family) member 2 (DHRS2) gene, which codes for an oxidoreductase that mitigates the breakdown of steroids. CONCLUSIONS: We found 3 novel loci associated with serum lycopene concentrations, 2 of which were specific to African Americans. Future functional studies looking at these specific genes may provide insight into the metabolism and underlying function of lycopene in humans, which may further elucidate lycopene's influence on disease risk and health. This trial was registered at clinicaltrials.gov as NCT00000611.
BACKGROUND: The consumption and blood concentrations of lycopene are both positively and inversely associated with the risk of several chronic diseases. The inconsistences in lycopene disease association studies may stem from a lack of knowledge about the genetic variation in the synthesis, metabolism, and deposition of transport and binding proteins, which potentially influence serum lycopene concentrations. OBJECTIVE: We examined the association between variation across the genome and serum concentrations of lycopene in a multiethnic population. METHODS:Participants included African (n = 914), Hispanic (n = 464), and European (n = 1203) American postmenopausal women from the Women's Health Initiative. We analyzed ∼7 million single nucleotide polymorphisms (SNPs). Linear regression models were used to assess associations between each SNP and serum concentrations (log transformed, continuous) of lycopene; we adjusted for age, body mass index, and population substructure. Models were run separately by ethnicity, and results were combined in a transethnic fixed-effects meta-analysis. RESULTS: In the meta-analysis, the scavenger receptor class B, member 1 (SCARB1) gene, which encodes for a cholesterol membrane transporter, was significantly associated with lycopene concentrations (rs1672879; P < 2.68 × 10(-9)). Each additional G allele resulted in a 12% decrease in lycopene concentrations for African Americans, 20% decrease for Hispanic Americans, and 9% decrease for European Americans. In addition, 2 regions were significantly associated with serum lycopene concentrations in African Americans: the slit homolog 3 gene (SLIT3), which serves as a molecular guidance cue in cellular migration, and the dehydrogenase/reductase (SDR family) member 2 (DHRS2) gene, which codes for an oxidoreductase that mitigates the breakdown of steroids. CONCLUSIONS: We found 3 novel loci associated with serum lycopene concentrations, 2 of which were specific to African Americans. Future functional studies looking at these specific genes may provide insight into the metabolism and underlying function of lycopene in humans, which may further elucidate lycopene's influence on disease risk and health. This trial was registered at clinicaltrials.gov as NCT00000611.
Keywords:
carotenoid metabolism; genetic variation; lycopene; multiethnic; nutritional epidemiology; postmenopausal women; scavenger receptor class B type 1 protein
Authors: Martha L Slattery; Abbie Lundgreen; Bill Welbourn; Roger K Wolff; Christopher Corcoran Journal: Mutat Res Date: 2012-04-15 Impact factor: 2.433
Authors: S Acton; D Osgood; M Donoghue; D Corella; M Pocovi; A Cenarro; P Mozas; J Keilty; S Squazzo; E A Woolf; J M Ordovas Journal: Arterioscler Thromb Vasc Biol Date: 1999-07 Impact factor: 8.311
Authors: Nicholas J Ollberding; Gertraud Maskarinec; Shannon M Conroy; Yukiko Morimoto; Adrian A Franke; Robert V Cooney; Lynne R Wilkens; Loïc Le Marchand; Marc T Goodman; Brenda Y Hernandez; Brian E Henderson; Laurence N Kolonel Journal: Blood Date: 2012-05-01 Impact factor: 22.113
Authors: Dagfinn Aune; Doris S M Chan; Ana Rita Vieira; Deborah A Navarro Rosenblatt; Rui Vieira; Darren C Greenwood; Teresa Norat Journal: Am J Clin Nutr Date: 2012-07-03 Impact factor: 7.045
Authors: Frank Thies; Lindsey F Masson; Amelia Rudd; Nicholas Vaughan; Catherine Tsang; Julie Brittenden; William G Simpson; Susan Duthie; Graham W Horgan; Garry Duthie Journal: Am J Clin Nutr Date: 2012-04-04 Impact factor: 7.045
Authors: Mary M Murphy; Leila M Barraj; Dena Herman; Xiaoyu Bi; Rachel Cheatham; R Keith Randolph Journal: J Acad Nutr Diet Date: 2012-02 Impact factor: 4.910
Authors: Bryan Howie; Christian Fuchsberger; Matthew Stephens; Jonathan Marchini; Gonçalo R Abecasis Journal: Nat Genet Date: 2012-07-22 Impact factor: 38.330
Authors: Nancy E Moran; Jennifer M Thomas-Ahner; Jessica L Fleming; Joseph P McElroy; Rebecca Mehl; Elizabeth M Grainger; Ken M Riedl; Amanda E Toland; Steven J Schwartz; Steven K Clinton Journal: J Nutr Date: 2019-03-01 Impact factor: 4.798
Authors: Kristi M Crowe-White; Venkata S Voruganti; Valentina Talevi; Tanja Dudenbostel; Vinoth A Nagabooshanam; Julie L Locher; Amy C Ellis Journal: Curr Dev Nutr Date: 2020-06-17
Authors: Vidya S Farook; Lavanya Reddivari; Srinivas Mummidi; Sobha Puppala; Rector Arya; Juan Carlos Lopez-Alvarenga; Sharon P Fowler; Geetha Chittoor; Roy G Resendez; Birunda Mohan Kumar; Anthony G Comuzzie; Joanne E Curran; Donna M Lehman; Christopher P Jenkinson; Jane L Lynch; Ralph A DeFronzo; John Blangero; Daniel E Hale; Ravindranath Duggirala; Jairam Kp Vanamala Journal: Am J Clin Nutr Date: 2017-05-17 Impact factor: 7.045
Authors: Terrence M Vance; Ying Wang; L Joseph Su; Elizabeth T H Fontham; Susan E Steck; Lenore Arab; Jeannette T Bensen; James L Mohler; Ming-Hui Chen; Ock K Chun Journal: Nutr Cancer Date: 2016-02-04 Impact factor: 2.900
Authors: Christopher R D'Adamo; Antonietta D'Urso; Kathleen A Ryan; Laura M Yerges-Armstrong; Richard D Semba; Nanette I Steinle; Braxton D Mitchell; Alan R Shuldiner; Patrick F McArdle Journal: Nutrients Date: 2016-02-06 Impact factor: 5.717
Authors: Ioana Mozos; Dana Stoian; Alexandru Caraba; Clemens Malainer; Jarosław O Horbańczuk; Atanas G Atanasov Journal: Front Pharmacol Date: 2018-05-23 Impact factor: 5.810